References
- Sanz MA, Fenaux P, Tallman MS, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 2019;133(15):1630–1643. doi:10.1182/blood-2019-01-894980
- Stahl M, Tallman MS. Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all. Leuk Lymphoma. 2019;60(13):3107–3115. doi:10.1080/10428194.2019.1613540
- Stahl M, Tallman MS. Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol. 2019;187(2):157–162. doi:10.1111/bjh.16151
- Montesinos P, Bergua JM, Vellenga E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood 2009;113(4):775–783. doi:10.1182/blood-2008-07-168617
- Abedin S, Altman JK. Acute promyelocytic leukemia: preventing early complications and late toxicities. Hematology Am Soc Hematol Educ Prog. 2016;2016(1):10–15. doi:10.1182/asheducation-2016.1.10
- Sanz MA, Montesinos P. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia. Blood 2014;123(18):2777–2782. doi:10.1182/blood-2013-10-512640
- Nicolls MR, Terada LS, Tuder RM, Prindiville SA, Schwarz MI. Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome. Am J Respir Crit Care Med. 1998;158(4):1302–1305. doi:10.1164/ajrccm.158.4.9709085
- Park CJ, Bae YD, Choi JY, et al. Sweet’s syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid. Korean J Intern Med. 2001;16(3):218–221. doi:10.3904/kjim.2001.16.3.218
- Newman AR, Leung B, Richards A, Campbell TG, Wellwood J, Imrie FR. Two cases of differentiation syndrome with ocular manifestations in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and arsenic trioxide. Am J Ophthalmol Case Rep. 2018;9:106–111. doi:10.1016/j.ajoc.2018.01.026
- Bhargava R, Dolai TK, Singhal D, Kumar R, Pathak P. Retinoic acid syndrome after first dose of ATRA and ileal perforation secondary to promyelocytes infiltration. Leuk Res. 2008;32(6):997–998. doi:10.1016/j.leukres.2007.09.021
- Kimura K, Takeuchi M, Hasegawa N, et al. [Severe stomatitis and ileocecal perforation developed after all-trans retinoic acid monotherapy in an HLA-B51-positive patient with acute promyelocytic leukemia]. Rinsho Ketsueki. 2016;57(6):765–770. doi:10.11406/rinketsu.57.765
- Yamamoto Y, Morii T, Kimura H. Paralytic ileus occurring during treatment with all-trans retinoic acid for acute promyelocytic leukemia. Int J Hematol. 2004;79(2):198–199. doi:10.1532/IJH97.03126